SEC Form 4 · accession 0001615774-17-001101

Vivani Medical, Inc. · VANI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Executive Officer

Period of report

Mar 14, 2017

Accepted (ET)

Mar 16, 2017 · 5:36 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001266806

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Mar 14, 2017	A	6,794	$1.47	A	59,798	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Warrant to Purchase Common Stock^F1	$1.47	Mar 14, 2017	A	6,794	A	Mar 14, 2017	Mar 14, 2022	Common Stock	6,794	6,794	D
Non-Qualified Stock Option (right to buy)^F2	$1.97	holding	—	—	—	Jan 3, 2018	Jan 3, 2027	Common Stock	571,330	571,330	D
Non-Qualified Stock Option (right to buy)^F2	$4.10	holding	—	—	—	Jan 21, 2017	Jan 21, 2026	Common Stock	21,290	21,290	D
Non-Qualified Stock Option (right to buy)^F2	$12.43	holding	—	—	—	Aug 17, 2016	Aug 17, 2025	Common Stock	420,000	420,000	D
Restricted Stock Unit (RSU)^F3,F2	—	holding	—	—	—	Aug 17, 2016	Aug 17, 2019	Common Stock	190,000	118,750	D

F1Common stock and warrants reported on this Form 4 pursuant to an exercise of subscription rights previously distributed by the Company to all holders of the Company's common stock. Each stockholder received a right to invest $0.47 for every share held of record on February 10, 2017, the record date, to purchase units consisting of one share of common stock and one warrant to purchase one share of common stock. The final allocation numbers of units were distributed on March 14, 2017.
F2Options and RSUs vest over a 4 year term, with 25% vesting on the date exercisable as set forth in this Form 4 and thereafter vesting in 12 equal quarterly installments of 6.25%.
F3Each restricted stock unit represents a contingent right to receive one share of common stock of the Company.